Table 5 Follow-up results for the 28 patients with BAE

VA Snellen

 20/400 or better

1 (3.6%)

8 (28.6%)

 CF

1 (3.6%)

1 (3.6%)

 HM

9 (32.2%)

8 (28.6%)

 LP

14 (50.0%)

6 (21.4%)

 NLP

3 (10.7%)

5 (17.9%)

 LogMAR

2.58 ± 0.27

2.14 ± 0.85

≤ 0.001

IOP (mmHg)

0.186

 Mean ± SD

18.7 ± 13.8

14.9 ± 6.0

 Range

3–60

7–37

The number of patients with IOP ≥ 30, n (%)

5 (17.9%)

1 (3.6%)

The number of patients with IOP ≤ 6, n (%)

1 (3.6%)

0 (0%)

The number of patients of normal IOP without surgery, n (%)

16 (57.1%)

22 (78.6%)

Further surgery for IOP control

5 (17.9%)

 Ahmed glaucoma valve implantation

3 (10.7%)

 Ex-PRESS implantation

1 (3.6%)

 Cyclophotocoagulation

1 (3.6%)

Enucleation

2 (7.1%)^a